PRA9 COSTS AND BENEFITS ASSOCIATED WITH ADDITION OF SALMETEROL VERSUS MONTELUKAST TO INHALED CORTICOSTEROID THERAPY IN A MEDICAID ASTHMATIC POPULATION
May 1, 2002, 00:00 AM
10.1016/S1098-3015(10)60983-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)60983-7/fulltext
Section Title :
Section Order :
171
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)60983-7&doi=10.1016/S1098-3015(10)60983-7